AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15652874 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone (600 mg/day)
Number of subjects: 20
Study 15652874 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 11853070 — intervention group
Group type: EXPERIMENTAL
Intervention: New catheter
Number of subjects: 76
Study 11853070 — intervention group
Group type: COMPARATOR
Intervention: Standard catheter
Number of subjects: 76
Study 11853070 — intervention group
Group type: COMPARATOR
Intervention: Left-sided catheters
Number of subjects: 76
Study 11853070 — intervention group
Group type: COMPARATOR
Intervention: Catheters inserted in females
Number of subjects: 76
Study 11853070 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheters removed for poor blood flow
Number of subjects: 76
Study 11853070 — intervention group
Group type: COMPARATOR
Intervention: Left-sided catheters and catheters in females
Number of subjects: 76
Study 11853070 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter design
Number of subjects: 76
Study 11048608 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemestane (aromatase inactivator)
Number of subjects: 0
Study 11048608 — intervention group
Group type: EXPERIMENTAL
Intervention: Third-generation aromatase inhibitors
Number of subjects: 0
Study 8790074 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen (20 mg/d)
Number of subjects: 68
Study 8790074 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study 1340245 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral hydration with rehydration salts
Number of subjects: 80
Study 1340245 — intervention group
Group type: COMPARATOR
Intervention: Parenteral hydration
Number of subjects: 80
Study 6147285 — intervention group
Group type: EXPERIMENTAL
Intervention: loprazolam (1.0 mg)
Number of subjects: 190
Study 6147285 — intervention group
Group type: EXPERIMENTAL
Intervention: nitrazepam (5.0 mg)
Number of subjects: 190
Study 6147285 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 190
Study 29851748 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Functional Exercise (HIFE) program, conducted in groups of 3 to 8 participants, led by two physiotherapists, 5 sessions (45 minutes each) per fortnight for 4 months (total 40 sessions).
Number of subjects: 93
Study 29851748 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Functional Exercise (HIFE) program.
Number of subjects: 93
Study 29205923 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based interval exercise training (12 weeks on a cycle ergometer)
Number of subjects: 26
Study 29205923 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based interval exercise training
Number of subjects: 26
Study 26312614 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise (AE)
Number of subjects: 19
Study 26312614 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Exercise (RE)
Number of subjects: 19
Study 24465561 — intervention group
Group type: EXPERIMENTAL
Intervention: Quiz-module with competition widgets
Number of subjects: 0
Study 24465561 — intervention group
Group type: COMPARATOR
Intervention: Quiz-module without competition widgets
Number of subjects: 0
Study 23662512 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral therapy
Number of subjects: 162
Study 20649501 — intervention group
Group type: EXPERIMENTAL
Intervention: Benidipine (2 mg/day increased to 8 mg/day)
Number of subjects: 233
Study 20649501 — intervention group
Group type: COMPARATOR
Intervention: Cilnidipine (5 mg/day increased to 20 mg/day)
Number of subjects: 233
Study 17704024 — intervention group
Group type: EXPERIMENTAL
Intervention: Low lactose infant formula supplemented with added precooked rice (1.5 g/100mL) with probiotic, prebiotic, fiber and increased amounts of zinc+iron
Number of subjects: 58
Study 17704024 — intervention group
Group type: COMPARATOR
Intervention: Low lactose infant formula with added precooked rice without the above active ingredient supplement
Number of subjects: 58
Study 15846251 — intervention group
Group type: EXPERIMENTAL
Intervention: GRD 180 mg evening dose
Number of subjects: 311
Study 15846251 — intervention group
Group type: EXPERIMENTAL
Intervention: GRD 360 mg evening dose
Number of subjects: 311
Study 15846251 — intervention group
Group type: COMPARATOR
Intervention: GRD 360 mg morning dose
Number of subjects: 311
Study 15846251 — intervention group
Group type: EXPERIMENTAL
Intervention: GRD 420 mg evening dose
Number of subjects: 311
Study 15846251 — intervention group
Group type: EXPERIMENTAL
Intervention: GRD 360 mg evening dose vs GRD 360 mg morning dose
Number of subjects: 311
Study 15846251 — intervention group
Group type: EXPERIMENTAL
Intervention: All GRD doses
Number of subjects: 311
Study 11768028 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 2 mg
Number of subjects: 260
Study 11768028 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 260
Study 9258843 — intervention group
Group type: EXPERIMENTAL
Intervention: 'do your best'
Number of subjects: 15
Study 9258843 — intervention group
Group type: EXPERIMENTAL
Intervention: 'improve by 10%' (easy)
Number of subjects: 15
Study 9258843 — intervention group
Group type: EXPERIMENTAL
Intervention: 'improve by 20%' (difficult/realistic)
Number of subjects: 15
Study 9258843 — intervention group
Group type: EXPERIMENTAL
Intervention: 'improve by 40%' (improbable/unattainable)
Number of subjects: 15
Study 9258843 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 weeks practice duration
Number of subjects: 15
Study 9258843 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 weeks practice duration
Number of subjects: 15
Study 9258843 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 weeks practice duration
Number of subjects: 15
Study 8251920 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon (IFN) treatment
Number of subjects: 230
Study 8251920 — intervention group
Group type: COMPARATOR
Intervention: Bone marrow transplantation (BMT)
Number of subjects: 230
Study 3645177 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational sessions designed to teach students various aspects of oral health
Number of subjects: 92
Study 3645177 — intervention group
Group type: COMPARATOR
Intervention: Oral examination control (Group one)
Number of subjects: 92
Study 3645177 — intervention group
Group type: EXPERIMENTAL
Intervention: Full series of self-care motivation curriculum sessions (Group five)
Number of subjects: 92
Study 2551359 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance therapy (CVM for 6 cycles)
Number of subjects: 68
Study 2551359 — intervention group
Group type: COMPARATOR
Intervention: No maintenance therapy (NM)
Number of subjects: 68
Study 2551359 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance therapy (CVM for 6 cycles) among patients in complete remission
Number of subjects: 68
Study 2551359 — intervention group
Group type: COMPARATOR
Intervention: No maintenance therapy (NM) among patients in complete remission
Number of subjects: 68
Study 31752508 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal and social rhythm therapy (IPSRT)
Number of subjects: 11
Study 31752508 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal and social rhythm therapy (IPSRT) with cognitive remediation
Number of subjects: 11
Study 30874292 — intervention group
Group type: EXPERIMENTAL
Intervention: Polylactic membrane (PLM)
Number of subjects: 0
Study 30874292 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrofiber dressing with silver (HFAg)
Number of subjects: 0
Study 30874292 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal children)
Number of subjects: 0
Study 28701300 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose infusion to the ileum (15 g, 235 kJ)
Number of subjects: 14
Study 28701300 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose infusion to the duodenum (15 g, 235 kJ)
Number of subjects: 14
Study 28701300 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion to the ileum
Number of subjects: 14
Study 28701300 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion to the duodenum
Number of subjects: 14
Study 25088240 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal locking Gamma 3 nail
Number of subjects: 177
Study 25088240 — intervention group
Group type: COMPARATOR
Intervention: Standard Gamma nail without distal locking
Number of subjects: 177
Study 24263289 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational tone content
Number of subjects: 1865
Study 24263289 — intervention group
Group type: COMPARATOR
Intervention: Prescriptive tone content
Number of subjects: 1865
Study 24263289 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple imputations accounting for time-outs
Number of subjects: 1865
Study 21257979 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 149
Study 21257979 — intervention group
Group type: COMPARATOR
Intervention: Strength training
Number of subjects: 149
Study 17993283 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate (5 mg/day, 35 mg/week, 50 mg/week, 15 mg/day)
Number of subjects: 1885
Study 17993283 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate
Number of subjects: 1885
Study 17993283 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1885
Study 17056774 — intervention group
Group type: EXPERIMENTAL
Intervention: Five behavioral counseling (BC) sessions
Number of subjects: 46
Study 17056774 — intervention group
Group type: COMPARATOR
Intervention: One behavioral counseling (BC) session
Number of subjects: 46
Study 15541915 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol delivered by dry powder inhaler (400 to 1600 microg)
Number of subjects: 6
Study 15541915 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol delivered by dry powder inhaler (1600 microg)
Number of subjects: 6
Study 15541915 — intervention group
Group type: EXPERIMENTAL
Intervention: Cascade impactor analysis (MSLI and ACI)
Number of subjects: 6
Study 11523499 — intervention group
Group type: EXPERIMENTAL
Intervention: Wellness-Based Mindfulness Stress Reduction intervention
Number of subjects: 103
Study 11523499 — intervention group
Group type: COMPARATOR
Intervention: Control group (educational materials and community resources)
Number of subjects: 103
Study 9249640 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioabsorbable demineralized laminar bone allograft membrane
Number of subjects: 12
Study 9249640 — intervention group
Group type: COMPARATOR
Intervention: Non-resorbable expanded polytetrafluoroethylene (ePTFE) membrane
Number of subjects: 12
Study 8518603 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiepileptic drug withdrawal
Number of subjects: 1013
Study 8518603 — intervention group
Group type: COMPARATOR
Intervention: Continued antiepileptic drug treatment
Number of subjects: 1013
Study 3031574 — intervention group
Group type: EXPERIMENTAL
Intervention: RIT 4237 bovine rotavirus vaccine
Number of subjects: 244
Study 3031574 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 244
Study 31096264 — intervention group
Group type: EXPERIMENTAL
Intervention: THC (one pill, administered 2 hours before threat extinction learning)
Number of subjects: 0
Study 31096264 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO, administered 2 hours before threat extinction learning)
Number of subjects: 0
Study 29183339 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG-triggered NMES with bilateral arm training
Number of subjects: 38
Study 29183339 — intervention group
Group type: COMPARATOR
Intervention: TENS with bilateral arm training
Number of subjects: 38
Study 25950418 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily oropharyngeal exercises
Number of subjects: 39
Study 25950418 — intervention group
Group type: COMPARATOR
Intervention: Nasal dilator strips plus respiratory exercises (control)
Number of subjects: 39
Study 22728314 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg of caffeine
Number of subjects: 20
Study 22728314 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 22728314 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 20
Study 21224837 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten (two bread slices plus one muffin per day for up to 6 weeks)
Number of subjects: 34
Study 21224837 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten
Number of subjects: 34
Study 21224837 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 19614944 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone 30 mg/day
Number of subjects: 299
Study 19614944 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 299
Study 16438766 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based CPR-D course
Number of subjects: 56
Study 16438766 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional small-group CPR-D course
Number of subjects: 56
Study 16438766 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific training in CPR-D)
Number of subjects: 56
Study 12852841 — intervention group
Group type: EXPERIMENTAL
Intervention: Loratadine (LOR) 20 mg
Number of subjects: 20
Study 11391146 — intervention group
Group type: COMPARATOR
Intervention: Closed hemorrhoidectomy with electrocautery
Number of subjects: 30
Study 11391146 — intervention group
Group type: EXPERIMENTAL
Intervention: Harmonic Scalpel hemorrhoidectomy
Number of subjects: 30
Study 9141231 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg atenolol per day (beta-blocker group)
Number of subjects: 25
Study 9141231 — intervention group
Group type: COMPARATOR
Intervention: 40 mg fosinopril per day alone (control group)
Number of subjects: 25
Study 7506156 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimesulide 100mg twice daily for three 10-day cycles
Number of subjects: 70
Study 7506156 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimesulide 200mg twice daily via rectal route
Number of subjects: 70
Study 7506156 — intervention group
Group type: COMPARATOR
Intervention: Ketoprofen 100mg twice daily via rectal route
Number of subjects: 70
Study 2962418 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg 17 beta‐estradiol cyclo‐octyl acetate (E2COA) and 0.15 mg desogestrel for 21 days, followed by 0.03 mg desogestrel for an additional 7 days in half the group
Number of subjects: 10
Study 2962418 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.03 mg desogestrel added during the fourth investigation week
Number of subjects: 10
Study 31992331 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic subgingival scaling combined with manual root planing
Number of subjects: 40
Study 31992331 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonic subgingival debridement
Number of subjects: 40
Study 31386610 — intervention group
Group type: EXPERIMENTAL
Intervention: Cediranib with platinum-pemetrexed
Number of subjects: 92
Study 31386610 — intervention group
Group type: COMPARATOR
Intervention: Placebo with platinum-pemetrexed
Number of subjects: 92
Study 28778747 — intervention group
Group type: EXPERIMENTAL
Intervention: HIGH load (2×10‐15 repetitions at 80% of one‐repetition maximum (1‐RM))
Number of subjects: 56
Study 28778747 — intervention group
Group type: EXPERIMENTAL
Intervention: LOW load (1×80‐100 repetitions at 20% of 1‐RM)
Number of subjects: 56
Study 28778747 — intervention group
Group type: EXPERIMENTAL
Intervention: LOW+ load (1×60 repetitions at 20% of 1‐RM, followed by 1×10‐20 repetitions at 40% 1‐RM)
Number of subjects: 56
Study 28778747 — intervention group
Group type: EXPERIMENTAL
Intervention: Detraining (after 24 weeks)
Number of subjects: 56
Study 25261956 — intervention group
Group type: EXPERIMENTAL
Intervention: Microdebrider surgery
Number of subjects: 26
Study 25261956 — intervention group
Group type: COMPARATOR
Intervention: CO2 laser surgery
Number of subjects: 26
Study 23279307 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg
Number of subjects: 584
Study 23279307 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 300 mg
Number of subjects: 584
Study 23279307 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 584
Study 21195195 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine (60 mg)
Number of subjects: 19
Study 21195195 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 18492834 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil capsules (5 mL/d, mean intake 3.1 g/d (n‐3) LCPUFA)
Number of subjects: 64
Study 18492834 — intervention group
Group type: COMPARATOR
Intervention: Olive oil capsules (control)
Number of subjects: 64
Study 17138310 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate pressure massage therapy
Number of subjects: 68
Study 17138310 — intervention group
Group type: COMPARATOR
Intervention: Light pressure massage therapy
Number of subjects: 68
Study 14578244 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin detemir (0.5 units/kg s.c.)
Number of subjects: 34
Study 14578244 — intervention group
Group type: COMPARATOR
Intervention: NPH insulin (0.5 IU/kg)
Number of subjects: 34
Study 10761170 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin 40 mg daily for 12 weeks
Number of subjects: 34
Study 10761170 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin
Number of subjects: 34
Study 8817416 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 0
Study 8817416 — intervention group
Group type: COMPARATOR
Intervention: Reduced dose radiotherapy with chemotherapy
Number of subjects: 0
Study 1386691 — intervention group
Group type: EXPERIMENTAL
Intervention: Methacholine inhalation (causing a nearly 20% fall in FEV1)
Number of subjects: 22
Study 1386691 — intervention group
Group type: EXPERIMENTAL
Intervention: Procaterol (30 micrograms)
Number of subjects: 22
Study 1386691 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 1386691 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 22
Study 6405435 — intervention group
Group type: EXPERIMENTAL
Intervention: d‐Amp (10 mg)
Number of subjects: 9
Study 6405435 — intervention group
Group type: EXPERIMENTAL
Intervention: d‐Amp (20 mg)
Number of subjects: 9
Study 6405435 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 30703100 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher BMI (1 kg/m2 increase)
Number of subjects: 396495
Study 30703100 — intervention group
Group type: COMPARATOR
Intervention: Psoriasis genetic risk
Number of subjects: 396495
Study 30253916 — intervention group
Group type: EXPERIMENTAL
Intervention: Mastery learning
Number of subjects: 40
Study 30253916 — intervention group
Group type: COMPARATOR
Intervention: Traditional learning
Number of subjects: 40
Study 26095261 — intervention group
Group type: EXPERIMENTAL
Intervention: Toric intraocular lens (IOL) implantation
Number of subjects: 52
Study 26095261 — intervention group
Group type: COMPARATOR
Intervention: Monofocal IOL implantation followed by PRK
Number of subjects: 52
Study 23384731 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 0.93% w/v
Number of subjects: 52
Study 20847729 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher Protein (HP, 25% of energy as protein, n = 14)
Number of subjects: 27
Study 20847729 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 eating occasions/day (3-EO) within HP group
Number of subjects: 27
Study 20847729 — intervention group
Group type: COMPARATOR
Intervention: Normal Protein (NP, 14% of energy as protein, n = 13)
Number of subjects: 27
Study 19262964 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-pharmacological strategies for treating BPSD
Number of subjects: 0
Study 19262964 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 17355644 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-discharge home visit by occupational therapist
Number of subjects: 10
Study 17355644 — intervention group
Group type: COMPARATOR
Intervention: Standard practice in-hospital assessment and education
Number of subjects: 10
Study 15297952 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot and hand massage (20 minutes, 5 minutes to each extremity) provided 1 to 4 hours after pain medication
Number of subjects: 18
Study 15297952 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot and hand massage
Number of subjects: 18
Study 12144221 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional phototherapy 23 hours per day and for the 24th hour were given KMC with a fiberoptic phototherapy panel held against their back
Number of subjects: 30
Study 12144221 — intervention group
Group type: COMPARATOR
Intervention: Traditional phototherapy 23 hours per day and for the 24th hour lay prone on a fiberoptic phototherapy panel
Number of subjects: 30
Study 12144221 — intervention group
Group type: COMPARATOR
Intervention: Traditional bank or spotlight phototherapy 24 hours per day
Number of subjects: 30
Study 9566646 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (20 mg day[-1])
Number of subjects: 41
Study 9566646 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (20 mg day[-1]) + omega-3 fatty acids (4 g day[-1])
Number of subjects: 41
Study 9566646 — intervention group
Group type: COMPARATOR
Intervention: omega-3 fatty acids (4 g day[-1])
Number of subjects: 41
Study 9360002 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril (20 mg once a day)
Number of subjects: 39
Study 9360002 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 2037324 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine administered intrapleurally
Number of subjects: 120
Study 2037324 — intervention group
Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 120
Study 6971108 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiaprofenic acid
Number of subjects: 7
Study 6971108 — intervention group
Group type: COMPARATOR
Intervention: Aluminum hydroxide
Number of subjects: 7
Study 6971108 — intervention group
Group type: COMPARATOR
Intervention: Acetylsalicylic acid
Number of subjects: 7
Study 31543428 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg every 2 weeks for 24 weeks (SINUS-24)
Number of subjects: 724
Study 31543428 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg every 2 weeks for 52 weeks (SINUS-52)
Number of subjects: 724
Study 31543428 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 724
Study 28380277 — intervention group
Group type: EXPERIMENTAL
Intervention: FoF cue (reactivation group)
Number of subjects: 89
Study 28380277 — intervention group
Group type: COMPARATOR
Intervention: Neutral cue (control group)
Number of subjects: 89